SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,444,176 | -23.7% | 502,586 | -2.7% | 0.81% | -19.9% |
Q1 2024 | $17,627,127 | +14.9% | 516,773 | -2.5% | 1.01% | +13.3% |
Q4 2023 | $15,336,811 | +2.2% | 529,952 | -2.7% | 0.89% | -6.8% |
Q3 2023 | $15,010,983 | -10.0% | 544,468 | -1.9% | 0.95% | +0.7% |
Q2 2023 | $16,677,081 | -16.5% | 554,793 | +0.6% | 0.95% | -16.7% |
Q1 2023 | $19,973,056 | -9.6% | 551,285 | -11.0% | 1.14% | -10.4% |
Q4 2022 | $22,091,394 | -3.9% | 619,327 | -8.8% | 1.27% | -5.0% |
Q3 2022 | $22,995,000 | -4.7% | 679,311 | -18.5% | 1.33% | +14.3% |
Q2 2022 | $24,118,000 | -12.7% | 833,952 | -2.5% | 1.17% | +5.9% |
Q1 2022 | $27,632,000 | +10.6% | 854,949 | -0.2% | 1.10% | +24.1% |
Q4 2021 | $24,986,000 | +2.4% | 856,855 | -6.3% | 0.89% | -1.7% |
Q3 2021 | $24,400,000 | -14.1% | 914,881 | -0.9% | 0.90% | -10.8% |
Q2 2021 | $28,415,000 | +4.9% | 922,859 | -10.8% | 1.01% | +14.5% |
Q1 2021 | $27,099,000 | +3.8% | 1,035,089 | -0.2% | 0.88% | -3.8% |
Q4 2020 | $26,100,000 | +24.0% | 1,037,378 | +2.7% | 0.92% | +8.3% |
Q3 2020 | $21,040,000 | -4.3% | 1,009,614 | +9.1% | 0.85% | -10.1% |
Q2 2020 | $21,980,000 | +28.9% | 925,486 | -2.3% | 0.94% | -1.0% |
Q1 2020 | $17,047,000 | -25.3% | 947,555 | -1.5% | 0.95% | +23.4% |
Q4 2019 | $22,818,000 | -11.4% | 961,973 | +2.7% | 0.77% | -16.2% |
Q3 2019 | $25,751,000 | -42.4% | 937,073 | -30.7% | 0.92% | -38.0% |
Q2 2019 | $44,714,000 | +27.6% | 1,351,286 | +35.1% | 1.48% | +31.5% |
Q1 2019 | $35,053,000 | +15.5% | 1,000,381 | +9.5% | 1.13% | +2.0% |
Q4 2018 | $30,354,000 | -5.6% | 913,736 | +43.0% | 1.11% | -3.8% |
Q3 2018 | $32,168,000 | -33.0% | 638,892 | -20.4% | 1.15% | -34.1% |
Q2 2018 | $48,039,000 | -19.4% | 802,661 | -38.3% | 1.75% | -24.9% |
Q1 2018 | $59,619,000 | +13.1% | 1,301,728 | -1.6% | 2.33% | +12.3% |
Q4 2017 | $52,706,000 | +7.6% | 1,322,614 | +8.0% | 2.07% | -4.4% |
Q3 2017 | $48,973,000 | -16.5% | 1,224,317 | -10.1% | 2.17% | -15.1% |
Q2 2017 | $58,675,000 | +71.4% | 1,361,373 | +24.5% | 2.55% | +53.1% |
Q1 2017 | $34,223,000 | +25.3% | 1,093,402 | +1.1% | 1.67% | +21.1% |
Q4 2016 | $27,314,000 | +82.8% | 1,081,740 | +79.0% | 1.38% | +76.3% |
Q3 2016 | $14,943,000 | +34.9% | 604,242 | +11.2% | 0.78% | +22.4% |
Q2 2016 | $11,073,000 | +35.4% | 543,606 | +1.3% | 0.64% | +35.2% |
Q1 2016 | $8,181,000 | +27.6% | 536,445 | +12.4% | 0.47% | +29.0% |
Q4 2015 | $6,412,000 | +123.0% | 477,068 | +132.8% | 0.37% | +96.8% |
Q3 2015 | $2,875,000 | +50.9% | 204,887 | +82.6% | 0.19% | +69.1% |
Q2 2015 | $1,905,000 | – | 112,189 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |